A condition, known commonly as "black urine disease" or Alkaptonuria is a rare genetic disorder involving protein metabolism, and it has its root in the mutation of the homogentisate 1,2-dioxygenase gene, which in turn causes homogentisic acid accumulation in the body. The appearance of dark urine after exposure to air is due to this kind of accumulation; however, a variety of symptoms can be expected, such as joint stiffness, changes in pigmentation, and other long-term health complications. Although the prevalence has been estimated to be between 1 in 250,000 and 1 in 1 million people in the United States, its effects are indeed high on those affected.

Alkaptonuria is an autosomal recessive disease, meaning that the child must inherit a defective copy of the HGD gene from both parents. If both parents are carriers, their offspring have a 25% chance of inheriting two faulty genes and developing alkaptonuria. The condition is genetic but is often not diagnosed for years because it progresses slowly and its early symptoms appear to be harmless.

Symptoms of Alkaptonuria

The most characteristic and common initial symptom of alkaptonuria is dark urine. The reason for this is due to the fact that excess HGA is excreted in the urine and upon oxidation in the presence of air, it gives the urine a brown or black color. Though it is often considered cosmetic, the long-term accumulation of HGA within the connective tissues produces more complicated health problems.

Progressive joint pain and stiffness: The accumulation of HGA in cartilage leads to early-onset osteoarthritis, making movement increasingly difficult over time.

Skin and eye pigmentation changes: Affected individuals may develop bluish or grayish discoloration of the sclera (white part of the eye) and the skin, particularly in areas exposed to friction.

Cardiovascular and respiratory problems: With age, HGA accumulation can lead to valve calcifications in the heart and stiffening of connective tissues in the respiratory tract, which can cause problems in middle and old age.

Decreased mobility and spinal problems: The spine may become stiff and painful due to chronic cartilage degeneration.

These symptoms usually begin to manifest during adulthood, leading to severe complications in a person's 40s or 50s and significantly affecting the quality of their life.

How is Alkaptonuria Diagnosed?

Because of its rarity, alkaptonuria is often mistaken or overlooked early in life. However, there are several ways to confirm the condition:

Urine Testing: The gold standard in the diagnosis is the testing of urine samples for high levels of homogentisic acid via gas chromatography. In case of oxidation, which changes the color of urine to black, it is indicative of alkaptonuria.

Genetic Testing: Confirmatory genetic testing reveals mutations of the HGD gene to diagnose the condition conclusively.

Blood Tests: High levels of HGA in the blood can be used as further evidence.

Imaging Studies: X-rays and MRIs will expose cartilage and joint damage characteristic of alkaptonuria.

Management of Alkaptonuria: Is There A Cure?

At present, there is no cure for alkaptonuria; however, various treatment approaches can reduce its symptoms and slow the disease's progress:

Nitisinone Therapy: Nitisinone is a drug that inhibits the production of HGA. It has been shown to reduce HGA levels and slow tissue damage. However, it needs to be taken under close medical supervision because of potential side effects.

Low-Protein Diet: Since HGA is a byproduct of protein metabolism, reducing protein intake—especially foods rich in tyrosine and phenylalanine—may help decrease HGA production.

Pain Management: OTC pain relievers and anti-inflammatory medications can be used to relieve joint pain and stiffness.

Physical Therapy: Exercise regularly, as it may improve mobility and strengthen muscles, thus reducing strain on affected joints.

Surgical Interventions: Most people with alkaptonuria develop severe osteoarthritis necessitating joint replacement in their old age. Also, some may require heart valve replacement surgery if cardiovascular complications develop.

Life with Alkaptonuria

Although alkaptonuria is not fatal, it severely affects the quality of life. The progressive deterioration of the joints and associated symptoms can make everyday activities difficult, requiring lifestyle changes and medical interventions. The disease may cause premature aging of the joints, requiring walking aids and mobility assistance earlier than expected.

Ongoing research will continue to work on improving the treatment options by focusing on gene therapy and alternative enzyme replacement therapies. However, because of its rarity, the clinical trials and research remain sparse.

As genetic research advances, more hope for better management and possible curative approaches for alkaptonuria exists. Scientists are searching extensively for enzyme replacement therapies and innovative drugs that can target the root cause of the disorder. Being aware and being diagnosed early helps individuals better their condition and ultimately have better long-term health outcomes.

Alkaptonuria is a striking example of how one gene mutation can have widespread effects on the body. Though still a rare and often misunderstood condition, growing awareness and advances in treatment are paving the way for better care. If you or a loved one suspect symptoms of alkaptonuria, it is essential to seek early diagnosis and medical guidance to manage the disease effectively and preserve quality of life.

Smoking has been long recognized as one of the worst habits a person can have, and Dr Jeremy London agrees with this statement. Dr. London, a cardiovascular surgeon, in a recent interview with Mel Robbins revealed that his number one advice as a heart doctor is to avoid smoking.

“I cannot come up with one single thing that does as much damage to every organ in the body as smoking cigarettes. And look, it's incredibly addictive and I know that and I pass no judgment because I know how difficult it is.”

He explained that in his practice he has dealt with chronic smokers for years and still believed that it is the single most dangerous thing one can do to themselves.

Also Read: Why Is It Harder For Women To Quit Smoking?

How Does Smoking Affect Other Organs?

Emphasizing how this one habit affects all organs in our body, Dr London mentioned the well-known link between lung cancer and smoking.

However, there are many more chronic diseases associated with the rest of the body that can develop due to smoking apart from lung conditions, according to the American Lung Association.

Here is what you should keep an eye out for:

Heart Disease

Also Read: 3 Science-Backed Methods To Quit Smoking For Good

Asthma

Reproductive Health

Vision Loss

Lung Cancer

Smoking is the leading cause of lung cancer, accounting for nearly 90 percent of all cases. Although medical treatments have improved, the five-year survival rate remains low. Quitting is the most effective way to lower your risk of this deadly disease.

Chronic Obstructive Pulmonary Disease

Other Cancers

Fasting for three hours before bed can significantly improve heart health and reduce the risk of coronary artery disease (CAD) as well as other chronic conditions, an Arteriosclerosis, Thrombosis, and Vascular Biology study suggests.

While many believe that diet plans such as intermittent fasting or time-restricted eating can help reduce their weight, researchers at Northwestern University have found that not eating three hours before going to sleep can reduce overnight blood pressure by nearly four percent, heart rate by five percent and strengthen overall heart rhythms.

This can help reduce overall strain on the heart which lowers risks for conditions like hypertension and CAD. Additionally, the scientists also discovered a drop in blood sugar levels, improved glucose tolerance and insulin sensitivity.

Participants who underwent glucose tests also showed better insulin release which tend to stabilize during the day. Additionally, an improved heart rate also lowered nighttime cortisol, which helped in metabolic balance.

Dr. Phyllis Zee, director of the Center for Circadian and Sleep Medicine and chief of sleep medicine in the department of neurology at Feinberg and corresponding author said of the results: "It's not only how much and what you eat, but also when you eat relative to sleep that is important for the physiological benefits of time-restricted eating."

The study authors also noted: "Extending overnight fasting duration by three hours in alignment with sleep improved cardiometabolic health in middle-aged/older adults by strengthening coordination between circadian- and sleep-regulated autonomic and metabolic activity.

"This sleep-aligned time-restricted eating approach represents a novel, accessible lifestyle intervention with promising potential for improving cardiometabolic function."

Coronary Artery Disease: The Silent Killer

Despite being as a common heart disease, coronary artery disease (CAD) develops over years and has no clear signs and symptoms apart from a heart attack. The illness begins due to a buildup of fats, cholesterol and other substances known as plaque in and on the artery walls.

Over time, this can cause narrowing or blockage of the coronary arteries and block the supply of oxygen-rich blood to heart which can lead chest pain (angina), shortness of breath and ultimately, heart attacks.

Typically, those above the age of 45, having a biological family member with heart disease, lack of sleep, smoking, consuming saturated fats along with other autoimmune diseases such as lupus and rheumatoid arthritis can increase the risk of developing CAD.

Treatment options may include medicines and surgery. Eating a nutritious diet, getting regular exercise and not smoking can help also prevent CAD and the conditions that can cause it.

Nearly one in 10 Indian adults suffer from CAD and about two million people die from the disease annually. Apart from this, about 18 to 20 million American adults aged 20 and older are also affected about the disease.

Strokes: A Rising Crisis In India

One in seven stroke patients in India are young adults aged below 45 years, with hypertension leading as the major risk factor, according to a study by the Indian Council of Medical Research (ICMR).

The Global Burden of Disease Study 2021 identified hypertension, air pollution, tobacco smoking, high cholesterol, increased salt intake, and diabetes as the leading risk factors of stroke.

Incidence of stroke is increasing significantly in low- and middle-income countries (LMICs), especially in India, due to population growth, aging, and greater exposure to risk factors.

Quitting smoking is one of the most important steps a person can take to improve their health. But research suggests that women face unique challenges that make it harder to stop smoking and remain nicotine-free as compared with men.

According to the Centers for Disease Control and Prevention, about 10 percent of women in the US currently smoke cigarettes. Each year, while many attempt to quit, maintaining long term abstinence remains difficult for a large number of smokers.

Scientists say these differences are not about motivation and women are usually just as willing to quit smoking as men. In many cases they are even more likely to seek help through smoking cessation programs, counseling or medical treatment.

However, the challenge lies in a combination of biological, psychological and social factors that can make nicotine addiction behave differently in women.

Nicotine Works Differently in Women’s Bodies

One of the biggest reasons for the difference is biological as women process nicotine differently than men.

Research shows that women tend to metabolize nicotine faster. This means nicotine leaves the body more quickly, which can lead to stronger withdrawal symptoms and more frequent cravings. Jean Perriot, MD, an addiction specialist at the Émile Roux Dispensary in France, says this biological difference can affect treatment.

Even though doctors sometimes worry about giving women too much nicotine replacement therapy, such as patches or gum, biological measurements often show that many women actually receive too little nicotine replacement, which can make treatment less effective.

Hormones also play a role in smoking behavior. Studies suggest that cravings may increase when estrogen levels are high and decrease when progesterone levels rise. These hormonal shifts occur naturally during the menstrual cycle and may influence when quitting attempts are most successful.

Stress And Emotions Can Trigger Smoking

Dr Nancy Rigotti, director of the Tobacco Research and Treatment Center at Massachusetts General Hospital who specializes in smoking cessation for many years notes that emotional triggers such as stress or depression can strongly influence smoking behavior among women.

Social and economic pressures may also increase vulnerability to tobacco use. Historically, the tobacco industry has targeted women with marketing campaigns that connect smoking with weight control, independence or attractiveness. Public health experts say these messages can shape attitudes about smoking and reinforce addictive behaviors.

Smoking Habits And Weight Concerns

Behavioral research suggests these cues may have a stronger influence for some women, which can make quitting harder even when nicotine dependence is treated.

Furthermore, nicotine can suppress appetite, leading may to pick up smoking to manage body weight. Studies show that women are more likely than men to experience increased cravings for high sugar or high fat foods after quitting smoking. They also tend to gain slightly more weight on average which can make some women hesitant to quit or more likely to relapse.

Treatments Work Differently for Women

Research suggests nicotine replacement therapy may need to be carefully adjusted because of faster nicotine metabolism in women. Some medications used to help people quit smoking may also have different effects.

For example, studies suggest the medication varenicline may cause more side effects in women, while the drug bupropion may be somewhat less effective for female smokers.

On the other hand, behavioral treatments appear to work well for many women. Cognitive behavioral therapy, which helps people understand and change unhealthy habits, may be slightly more effective for women than men. Women are also more likely to try complementary approaches such as meditation, yoga or hypnosis when attempting to quit smoking.

Toward More Personalized Quit Strategies

Exposure to secondhand smoke is another concern. Studies show women are often more likely to be exposed to tobacco smoke at home or in shared environments. Some research also suggests women may face higher risks of certain tobacco related diseases even at lower levels of smoking.

Understanding these differences can help doctors design better quitting strategies. Scientists say the goal is not simply to encourage people to quit smoking, but to provide the right tools so that quitting becomes more achievable for everyone.